BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 28062641)

  • 1. Melatonin levels in follicular fluid as markers for IVF outcomes and predicting ovarian reserve.
    Tong J; Sheng S; Sun Y; Li H; Li WP; Zhang C; Chen ZJ
    Reproduction; 2017 Apr; 153(4):443-451. PubMed ID: 28062641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures.
    Zheng M; Tong J; Li WP; Chen ZJ; Zhang C
    Gynecol Endocrinol; 2018 May; 34(5):446-450. PubMed ID: 29185361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
    Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
    Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular fluid humanin concentration is related to ovarian reserve markers and clinical pregnancy after IVF-ICSI: a pilot study.
    Rao M; Zhou F; Tang L; Zeng Z; Hu S; Wang Y; Ke D; Cheng G; Xia W; Zhang L; Zhu C
    Reprod Biomed Online; 2019 Jan; 38(1):108-117. PubMed ID: 30503199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
    Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
    Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the anti-Müllerian hormone truly reflect ovarian response in women with endometrioma?
    Inal ZO; Engin Ustun Y; Yilmaz N; Aktulay A; Bardakci Y; Gulerman C
    J Obstet Gynaecol; 2019 May; 39(4):516-521. PubMed ID: 30744464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular fluid anti-Müllerian hormone: a predictive marker of fertilization capacity of MII oocytes.
    Tramišak Milaković T; Panić Horvat L; Čavlović K; Smiljan Severinski N; Vlašić H; Vlastelić I; Ljiljak D; Radojčić Badovinac A
    Arch Gynecol Obstet; 2015 Mar; 291(3):681-7. PubMed ID: 25205183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of follicular fluid phthalate metabolites on the ovarian reserve and ovarian function in Indian women undergoing intracytoplasmic sperm injection.
    Parikh FR; Uttamchandani S; Sawkar S; Panpalia M; Naik N; Sinkar P; Kulkarni D; Parikh R
    F S Sci; 2024 May; 5(2):107-120. PubMed ID: 38219085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of AMH on IVF success.
    Gomez R; Schorsch M; Hahn T; Henke A; Hoffmann I; Seufert R; Skala C
    Arch Gynecol Obstet; 2016 Mar; 293(3):667-73. PubMed ID: 26449238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free nucleic acids and melatonin levels in human follicular fluid predict embryo quality in patients undergoing in-vitro fertilization treatment.
    Latif Khan H; Bhatti S; Latif Khan Y; Abbas S; Munir Z; Rahman Khan Sherwani IA; Suhail S; Hassan Z; Aydin HH
    J Gynecol Obstet Hum Reprod; 2020 Jan; 49(1):101624. PubMed ID: 31472269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.
    La Marca A; Minasi MG; Sighinolfi G; Greco P; Argento C; Grisendi V; Fiorentino F; Greco E
    Fertil Steril; 2017 Nov; 108(5):777-783.e2. PubMed ID: 28987789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone and progesterone levels in human follicular fluid are predictors of embryonic development.
    O'Brien Y; Wingfield M; O'Shea LC
    Reprod Biol Endocrinol; 2019 Jun; 17(1):47. PubMed ID: 31217014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrafollicular melatonin concentration is elevated in patients with ovarian hyperstimulation syndrome (OHSS) and can serve as an important predictor of OHSS.
    Zheng M; Zuo G; Tong J; Chen ZJ; Li WP; Zhang C
    Arch Gynecol Obstet; 2019 Apr; 299(4):1151-1158. PubMed ID: 30725184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the practice of LuPOR for poor responders: a prospective study evaluating follicular fluid cfDNA levels during natural IVF cycles.
    Sfakianoudis K; Tsioulou P; Maziotis E; Giannelou P; Glava A; Grigoriadis S; Rapani A; Nezos A; Pantou A; Koutsilieris M; Pantos K; Mastorakos G; Simopoulou M
    J Assist Reprod Genet; 2020 May; 37(5):1183-1194. PubMed ID: 32221790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.